Trial Details

UNKNOWN
Basic Information
Clinical ID c2684
Identifier NCT03108326
Trial Title Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Crohn Disease
Interventions BIOLOGICAL: Stelara, Remicade, Entyvio, Humira, Remsima, Flixabi, Inflectra
Participant Information
Sponsor Ced Service GmbH
City Lower Saxony
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2017-04-15
Primary Completion Date 2023-03-31
Completion Date 2023-03-31